Controlled trial of enviroxime against natural rhinovirus infections in a community
Open Access
- 1 January 1985
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 27 (1) , 102-106
- https://doi.org/10.1128/aac.27.1.102
Abstract
The therapeutic effect of intranasally administered enviroxime was tested against naturally occurring common colds. The double-blind evaluation was carried out in Tecumseh, Mich., during a period when rhinoviruses are usually the principal pathogen. Rhinovirus transmission followed the typical pattern during this period of study. Although there were trends indicating greater therapeutic effectiveness for enviroxime when certain nasal symptoms were considered, there were no consistent statistically significant differences between treated and untreated groups. Results were unchanged when illnesses in different periods or associated with rhinovirus isolation were examined. It was concluded that no therapeutic effect of enviroxime was demonstrated.This publication has 6 references indexed in Scilit:
- Therapeutic activity of enviroxime against rhinovirus infection in volunteersAntimicrobial Agents and Chemotherapy, 1983
- Prophylactic activity of intranasal enviroxime against experimentally induced rhinovirus type 39 infectionAntimicrobial Agents and Chemotherapy, 1982
- THE ACTIVITY OF ENVIROXIME AGAINST RHINOVIRUS INFECTION IN MANThe Lancet, 1981
- Inhibition of Rhinovirus Replication in Organ Culture by a Potential Antiviral DrugThe Journal of Infectious Diseases, 1980
- A computer program for testing average partial association in three-way contingency tables (PARCAT)Computer Programs in Biomedicine, 1979
- THE TECUMSEH STUDY OF RESPIRATORY ILLNESSIV. PREVALENCE OF RHINOVIRUS SEROTYPES, 1966–196912American Journal of Epidemiology, 1972